Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine

Vaccine

Volumn 26, Issue 8, 2008, Pages 1032-1037

  Fernandes, Sérgio Júlio ^a   Slhessarenko, Natasha ^b   Souto, Francisco José Dutra ^b  

^a Secretaria de Saúde do Estado de Mato Grosso   (Brazil)

^b UNIVERSIDADE FEDERAL DE MATO GROSSO   (Brazil)

Author keywords

Children; Hepatitis B vaccine; Perinatal HIV transmission

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ANTIBODY PRODUCTION; ARTICLE; BIRTH WEIGHT; BREAST FEEDING; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VACCINATION; VERTICAL TRANSMISSION; VIRUS TITRATION;

BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HIV INFECTIONS; HUMANS; INFANT; MALE;

EID: 39149088951     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.12.020     Document Type: Article

References (21)

1. Kao J.H., and Chen D.S. Global control of hepatitis B virus infection. Lancet Infect Dis 2 7 (2002) 395-403
2. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR Morb Mortal Wkly Rep 54 (2005) [RR-16]
3. Shouval D. Hepatitis B vaccines. J Hepatol 39 (2003) S70-S76
4. Saffar M.J., and Rezai M.S. Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth. Indian Pediatr 41 12 (2004) 1232-1237
5. Llop L.A.G., Alcoverro A.A., Más P.C., Benedito M.A.R., and Juan C.G. Títulos de anti-HBs trás um programa de vacunación em niños y adolescentes: revacunar?. An Esp Pediatr 54 (2001) 32-37
6. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. New Engl J Med 336 26 (1997) 1855-1859
7. Gust I.D. Immunization against hepatitis B in Taiwan. Gut 38 Suppl. 2 (1996) 67-68
8. Da Villa G., Peluso F., Picciotto L., Bencivenga M., Elia S., and Pelliccia M.G. Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years. Vaccine 14 16 (1996) 1503-1505
9. Watanaveeradej V., Samakoses R., Kerdpanich A., Aree C., Nitayabhan S., Viputtikul K., et al. Antibody response to hepatitis B vaccine in infants of HIV-positive mothers. Int J Infect Dis 6 3 (2002) 240-241
10. Zuin G., Principi N., Tornaghi R., Paccagnini S., Re M., Massironi, et al. Impaired response to hepatitis B vaccine in HIV infected children. Vaccine 10 12 (1992) 857-860
11. Choudhury S.A., and Peters V.B. Responses to hepatitis B vaccine boosters in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 14 (1995) 65-67
12. Scolfaro C., Flammengo P., Balbo L., Madon E., and Tovo P.-A. Hepatitis B vaccination in HIV-1 children: double efficacy doubling the paediatric dose. AIDS 10 (1996) 1169-1182
13. Martins R.M., Bensabath G., Arraes L.C., Oliveira M.L.A., Miguel J.C., Barbosa G.G., et al. Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B. Mem Inst Oswaldo Cruz 99 (2004) 865-871
14. Ribeiro T.M., and Azevedo R.S. Seroconversion of hepatitis B vaccine in infants related to the mother's serostatus in a community of São José dos Campos, State of São Paulo, Brazil. Clinics 61 (2006) 387-394
15. Diamant E.P., Schechter C., Hodes D.S., and Peters V.B. Immunogenicity of hepatitis B vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 12 10 (1993) 877-878
16. Moss W.J., Clements C.J., and Halsey N.A. Immunization of children at risk of infection with human immunodeficiency virus. Bull WHO 81 1 (2003) 61-70
17. Obaro S.K., Pugatch D., and Luzuriaga K. Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. Lancet Infect Dis 4 8 (2004) 510-518
18. Siriaksorn S., Puthanakit T., Sirisanthana T., and Sirisanthana V. Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine 24 16 (2006) 3095-3099
19. Wong E.K.L., Bodsworth N.J., Slade M.A., Mulhall B.P., and Donovan B. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS 7 (1996) 490-494
20. Bekker V., Scherpbier H., Pajkrt D., Jurriaans S., Zaaijer H., and Kuijpers T. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 118 2 (2006) e315-e322
21. Lao-araya M., Puthanakit T., Aurpibul L., Sirisanthana T., and Sirisanthana V. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy. Vaccine 25 29 (2007) 5324-5329